AstraZeneca's $4 billon Xmas present

ReutersNewsPublished: December 17, 201535 views
Published: December 17, 2015

M&A in the pharma sector marches on unabated - AstraZeneca buying a 55 percent stake in biotech Acerta Pharma for $4.0 billion to give it new cancer drugs. Hayley Platt reports.

Be the first to suggest a tag